Inhibikase Therapeutics Inc
NASDAQ:IKT

Watchlist Manager
Inhibikase Therapeutics Inc Logo
Inhibikase Therapeutics Inc
NASDAQ:IKT
Watchlist
Price: 1.72 USD 2.99% Market Closed
Market Cap: 208.6m USD

Wall Street
Price Targets

IKT Price Targets Summary
Inhibikase Therapeutics Inc

Wall Street analysts forecast IKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IKT is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
194% Upside
Average
Price Target
7.14 USD
315% Upside
Highest
Price Target
8.4 USD
388% Upside
Inhibikase Therapeutics Inc Competitors:
Price Targets
DVAX
Dynavax Technologies Corp
95% Upside
GNFT
Genfit SA
78% Upside
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
SPRB
Spruce Biosciences Inc
171% Upside
ADOC
Adocia SA
136% Upside
ORGO
Organogenesis Holdings Inc
55% Upside
688331
RemeGen Co Ltd
14% Upside
096530
Seegene Inc
74% Upside

Revenue
Forecast

Revenue Estimate
Inhibikase Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Inhibikase Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Inhibikase Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IKT's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for IKT is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Back to Top